Saraf-dependent activation of mTORC1 regulates cardiac growth.


Journal

Journal of molecular and cellular cardiology
ISSN: 1095-8584
Titre abrégé: J Mol Cell Cardiol
Pays: England
ID NLM: 0262322

Informations de publication

Date de publication:
04 2020
Historique:
received: 16 05 2019
revised: 03 03 2020
accepted: 09 03 2020
pubmed: 17 3 2020
medline: 29 5 2021
entrez: 17 3 2020
Statut: ppublish

Résumé

Pathological cardiac hypertrophy is an independent risk for heart failure (HF) and sudden death. Deciphering signaling pathways regulating intracellular Ca

Identifiants

pubmed: 32173353
pii: S0022-2828(20)30059-6
doi: 10.1016/j.yjmcc.2020.03.004
pii:
doi:

Substances chimiques

Calcium-Binding Proteins 0
Membrane Proteins 0
Saraf protein, mouse 0
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

30-42

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None

Auteurs

Ayse Sanlialp (A)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Dagmar Schumacher (D)

DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Institute of Pharmacology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany.

Leon Kiper (L)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Eshita Varma (E)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Eva Riechert (E)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Thanh Cao Ho (TC)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Christoph Hofmann (C)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Vivien Kmietczyk (V)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Frank Zimmermann (F)

Interfacultary Biomedical Faculty (IBF), University of Heidelberg, Im Neuenheimer Feld 347, 69120 Heidelberg, Germany.

Sascha Dlugosz (S)

Interfacultary Biomedical Faculty (IBF), University of Heidelberg, Im Neuenheimer Feld 347, 69120 Heidelberg, Germany.

Angela Wirth (A)

DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Institute of Pharmacology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany.

Agnieszka A Gorska (AA)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Jana Burghaus (J)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Juan E Camacho Londoño (JE)

DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Institute of Pharmacology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany.

Hugo A Katus (HA)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Shirin Doroudgar (S)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany.

Marc Freichel (M)

DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany; Institute of Pharmacology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 366, 69120 Heidelberg, Germany.

Mirko Völkers (M)

Department of Cardiology, Angiology, and Pneumology, University Hospital Heidelberg, University of Heidelberg, Im Neuenheimer Feld 669, 69120 Heidelberg, Germany; DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, 69120 Heidelberg, Germany. Electronic address: mirko.voelkers@med.uni-heidelberg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH